New Low-Energy Radiation System for Eye Cancer Treatment
Author Information
Author(s): Carlos Esquivel Jr, Clifton D Fuller, Robert G Waggener, Adrian Wong, Martin Meltz, Melissa Blough, Tony Y Eng, Charles R Thomas Jr
Primary Institution: Cancer Therapy and Research Center, San Antonio, TX, USA
Hypothesis
Can the BLOKX system provide better dose distribution for treating choroidal melanoma compared to traditional methods?
Conclusion
The BLOKX technique allows for a more favorable dose distribution compared to standard brachytherapy, potentially reducing damage to surrounding eye structures.
Supporting Evidence
- The BLOKX technique showed a significant reduction of dose, 89.8%, to the macula compared to the episcleral plaque.
- A minimum 71.0% decrease in dose to the optic nerve occurred when the BLOKX was used.
- Tumor-base doses ranged from 87.1–102.8 Gy for the BLOKX procedure, compared to 335.3–338.6 Gy for the eye-plaque procedure.
Takeaway
The BLOKX system is a new way to treat eye cancer that can help protect important parts of the eye while still targeting the tumor.
Methodology
Monte Carlo simulations were used to compare the BLOKX system with traditional eye-plaque brachytherapy in terms of dose distribution to tumor and surrounding tissues.
Limitations
The study is based on simulations and may not fully represent clinical outcomes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website